Novartis Seeks To Nix Expert Testimony In Bone Drug MDL
Novartis Pharmaceuticals Corp. asked a Tennessee federal judge on Thursday to exclude six experts' testimony in 30 suits in a multidistrict litigation over the bone cancer drugs Aredia and Zometa, the...To view the full article, register now.
Already a subscriber? Click here to view full article